Showing results (631-640 of 3,096) with videos related to
Sort By:
Pageof 310
Expert Review of Anticancer Therapy|January 23, 2026
From fecal microbiota transplants to targeted intervention for improvement of immune checkpoint inhibition therapy: how far down the road are we?Madieke Kleinhans, Anouk Lissen, Lucy Hewitson, et al.Expert Review of Anticancer Therapy|January 16, 2026
Concomitant use of H1 antihistamines improves survival outcomes in cancer patients on immune checkpoint inhibitor therapy: a systematic review and meta-analysisFrancisco Cezar Aquino de Moraes, Pedro Henrique de Souza Wagner, Rosario Dominguez Crespo Hirata, et al.Expert Review of Anticancer Therapy|January 19, 2026
REGULATORY LANDSCAPE FOR CAR-T THERAPY DEVELOPMENT IN THE BRAZILIAN CONTEXTFelipe Pantoja Mesquita, Marília Silveira Maia, Pedro Filho Noronha Souza, et al.Expert Review of Anticancer Therapy|December 31, 2025
Prognostic factors of undifferentiated embryonal sarcoma of the liver in children: a SEER-based studyQiu Jin, Yehang Zhu, Zhaopeng HeExpert Review of Anticancer Therapy|December 29, 2025
Quality of life in ovarian cancer patients receiving maintenance therapy with bevacizumab versus PARPi: a network meta-analysisDi Wu, Zirong Wang, Wei Yang, et al.Expert Review of Anticancer Therapy|March 23, 2023
Novel breakthroughs in advanced prostate cancer managementEddy Lilly, Julien Sarkis, Omar Mahmoud, et al.Expert Review of Anticancer Therapy|March 23, 2023
Overview and recent advances in incidental meningiomaOlivia Näslund, Per Sveino Strand, Thomas Skoglund, et al.Expert Review of Anticancer Therapy|February 16, 2023
Outcomes after the watch-and-wait strategy and local excision treatment for rectal cancer: a meta-analysisJinghui Li, Yongli Ma, Liang Wen, et al.Expert Review of Anticancer Therapy|February 21, 2023
Overview of the synergistic use of radiotherapy and immunotherapy in cancer treatment: current challenges and scopes of improvementRiccardo Ray Colciago, Irene Fischetti, Carlotta Giandini, et al.Expert Review of Anticancer Therapy|February 3, 2023
Prognostic and clinicopathological value of CDK12 mutation in prostate cancer: a meta-analysisWenjian Zhang, Lushan Zhou, Jianzhong DiPageof 310